Last reviewed · How we verify
ShigETEC live, attenuated, oral vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
ShigETEC live, attenuated, oral vaccine (ShigETEC live, attenuated, oral vaccine) — Eveliqure Biotechnologies GmbH.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ShigETEC live, attenuated, oral vaccine TARGET | ShigETEC live, attenuated, oral vaccine | Eveliqure Biotechnologies GmbH | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ShigETEC live, attenuated, oral vaccine CI watch — RSS
- ShigETEC live, attenuated, oral vaccine CI watch — Atom
- ShigETEC live, attenuated, oral vaccine CI watch — JSON
- ShigETEC live, attenuated, oral vaccine alone — RSS
Cite this brief
Drug Landscape (2026). ShigETEC live, attenuated, oral vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/shigetec-live-attenuated-oral-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab